Paul Weiss and McCann FitzGerald advise Alkermes plc on its $2.1 billion acquisition of Avadel Pharmaceuticals plc, with Goodwin Procter and Arthur Cox advising Avadel.
Alkermes plc acquired the target/assets from Avadel Pharmaceuticals plc in an acquisition. Date not available.
Deal value was 2100000000. Sector: Biopharmaceuticals; Location: not available.
On the acquirer side, legal advice was provided by a team including Chelsea Darnell, James Langston, Timothy Cruickshank, Daniel Gerkin, Nathan Mitchell, Matthew Friestedt, Jeffrey Osterman, John Patten, Matthew Rosenberg, Alex Zapalowski, Brian Krause, Geoffrey Chepiga, Elizabeth Weiswasser, Audrey Paquet, Natalie Kennedy, Nicole Kar, Scott Sher, John Magruder.
Generated by AI, original source from - Data is in progress
Avadel Pharmaceuticals plc advisor
Firm name is in progress
Found it useful? Spread the word.
Paul Weiss and McCann FitzGerald advise Alkermes plc on its $2.1 billion acquisition of Avadel Pharmaceuticals plc, with Goodwin Procter and Arthur Cox advising Avadel. | The Sponsor - The Sponsor
